Zhang Yijing, Yao Yi, Du Weixing, Wu Kai, Xu Wenyue, Lin Min, Tan Huabing, Li Jian
a Department of Human Parasitology, College of Basic Medicine; Department of Infectious Diseases , Renmin Hospital, Hubei University of Medicine , Shiyan , People's Republic of China.
b Department of Schistosomiasis and Endemic Diseases , Wuhan City Center for Disease Prevention and Control , Wuhan , People's Republic of China.
Pathog Glob Health. 2017 Jul;111(5):247-255. doi: 10.1080/20477724.2017.1347379. Epub 2017 Jul 6.
In order to achieve better outcomes for treatment and in the prophylaxis of malaria, it is imperative to develop a sensitive, specific, and accurate assay for early diagnosis of Plasmodium falciparum infection, which is the major cause of malaria. In this study, we aimed to develop a loop-mediated isothermal amplification (LAMP) assay with P. falciparum unique genes for sensitive, specific, and accurate detection of P. falciparum infection. The unique genes of P. falciparum were randomly selected from PlasmoDB. The LAMP primers of the unique genes were designed using PrimerExplorer V4. LAMP assays with primers from unique genes of P. falciparum and conserved 18S rRNA gene were developed and their sensitivity was assessed. The specificity of the most sensitive LAMP assay was further examined using genomic DNA from Plasmodium vivax, Plasmodium yoelii and Toxoplasma gondii. Finally, the unique gene-based LAMP assay was validated using clinical samples of P. falciparum infection cases. A total of 31 sets of top-scored LAMP primers from nine unique genes were selected from the pools of designed primers. The LAMP assay with PF3D7_1253300-5 was the most sensitive with the detection limit 5 parasites/μl, and it displayed negative LAMP assay with the genomic DNA samples of P. vivax, P. yoelii, and T. gondii. The LAMP assay with PF3D7_0112300 (18S rRNA) was less sensitive with the detection limit 50 parasites/μl, and it displayed negative LAMP assay with the genomic DNA samples of P. yoelii and T. gondii, but displayed positive LAMP detection with P. vivax. The positive detection rate of the LAMP assay with PF3D7_1253300-5 was 90% (27/30), higher than that (80%, 24/30) of the positive rate of PF3D7_0112300 (18S rRNA) in examining clinical samples of P. falciparum infection cases. The LAMP assay with the primer set PF3D7_1253300-5 was more sensitive, specific, and accurate than those with PF3D7_0112300 (18S rRNA) in examining P. falciparum infection, and therefore it is a promising tool for diagnosis of P. falciparum infection.
为了在疟疾治疗和预防方面取得更好的效果,开发一种灵敏、特异且准确的检测方法用于早期诊断恶性疟原虫感染至关重要,因为恶性疟原虫感染是疟疾的主要病因。在本研究中,我们旨在开发一种基于恶性疟原虫独特基因的环介导等温扩增(LAMP)检测方法,用于灵敏、特异且准确地检测恶性疟原虫感染。恶性疟原虫的独特基因是从PlasmoDB中随机选取的。使用PrimerExplorer V4设计了这些独特基因的LAMP引物。开发了基于恶性疟原虫独特基因引物和保守的18S rRNA基因引物的LAMP检测方法,并评估了它们的灵敏度。使用间日疟原虫、约氏疟原虫和刚地弓形虫的基因组DNA进一步检测了最灵敏的LAMP检测方法的特异性。最后,使用恶性疟原虫感染病例的临床样本对基于独特基因的LAMP检测方法进行了验证。从设计的引物库中总共选择了来自9个独特基因的31组得分最高的LAMP引物。PF3D7_1253300 - 5引物的LAMP检测方法最灵敏,检测限为5个寄生虫/微升,并且对间日疟原虫、约氏疟原虫和刚地弓形虫的基因组DNA样本显示LAMP检测为阴性。PF3D7_0112300(18S rRNA)引物的LAMP检测方法灵敏度较低,检测限为50个寄生虫/微升,对约氏疟原虫和刚地弓形虫的基因组DNA样本显示LAMP检测为阴性,但对间日疟原虫显示LAMP检测为阳性。在检测恶性疟原虫感染病例的临床样本时,PF3D7_1253300 - 5引物的LAMP检测方法的阳性检出率为90%(27/30),高于PF3D7_0112300(18S rRNA)引物的阳性率(80%,24/30)。在检测恶性疟原虫感染方面,PF3D7_1253300 - 5引物组的LAMP检测方法比PF3D7_0112300(18S rRNA)引物组的LAMP检测方法更灵敏、特异且准确,因此它是诊断恶性疟原虫感染的一种有前景的工具。